The Generative AI in Drug Discovery Market was valued at USD 138.5 Million in 2023. It is expected to reach USD 1,435.0 Million by 2033, with a CAGR of 27.1% ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

A new quantum-classical approach speeds up the discovery of photochromic materials. A joint research team has developed an ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

PureTech Founded Entity Seaport Therapeutics Announces Publication of New Research Demonstrating Increased Lymphatic Transport with Glyph Platform ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

There are many molecules with therapeutic potential, but it can be a challenge to deliver them to the right places at the ...

Founded by Professors Omar Abudayyeh, Jonathan Gootenberg, and Patrick Hsu leveraging novel AI models and technologies for designing, building, and delivering RNA- Raised $9M in seed funding from ...

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

NTT Research, Inc., a division of NTT (TYO:9432), and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced the publication of research showing an application of ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...